Sort
48,018 grants matching “immunotherapy”
Modulation of B Cell Responses in Autoimmunity
$747,316Eugene W. St Clair · Duke University · U19 · FY2006 · AI
Mechano-chemical regulation of the microenvironmental niche in melanoma
$747,231Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$747,163Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
$746,809Stephen C Mack · St. Jude Children'S Research Hospital · U01 · FY2024 · CA
Cancer Center Support (Core) Grant
$746,692Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2016 · CA
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$746,671Shabaana A. Khader · Washington University · R01 · FY2016 · AI
Discovery of novel tau proteoforms as biomarker candidates for AD and PSP
$746,667Jeffrey Dage · Indiana University Indianapolis · R01 · FY2024 · AG
Preclinical Studies of Tregitope Delivery and Mechanism of Action in T1D
$746,662Anne Searls De Groot · Epivax, Inc. · R44 · FY2012 · DK
Regulation of human dendritic cell activation
$746,624Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Discovering and characterizing the germline mechanisms of cutaneous immune-related adverse events (cirAE)
$746,572Nicole R Leboeuf · Brigham And Women'S Hospital · R01 · FY2025 · AR
Receptor Mediated T and B Cell Activation
$746,520Richard J. Hodes · Basic Sciences · Z01 · FY2007 · CA
Biology of α-linked glycosylceramides in the immune system
$746,384Luc Teyton · Scripps Research Institute, The · R01 · FY2017 · AI
Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population
$746,282Eliezer Masliah · National Institute On Aging · ZIA · FY2017 · AG
Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen
$746,269Antoni Ribas · California Institute Of Technology · P01 · FY2010 · CA
Developmental Funds
$746,047Candace S Johnson · Roswell Park Cancer Institute Corp · P30 · FY2024 · CA
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$746,045James D. Marks · University Of California, San Francisco · U01 · FY2009 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$745,628M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2021 · AI
Islet-specific CD8 T cells in the pathogenesis of type 1 diabetes
$745,583Maki Nakayama · University Of Colorado Denver · R01 · FY2025 · DK
Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes
$745,410Alphonsus Ng · University Of Utah · R01 · FY2022 · DK
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$745,334Andrew Sikora · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · DE
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism
$745,309Joren C Madsen · Massachusetts General Hospital · P01 · FY2025 · HL
Structure, Function and Mechanistic Analysis of LAG3
$745,225Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping
$745,169Han Zhu · Stanford University · R01 · FY2025 · HL
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
$745,005Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
$744,981Marina Caskey · Rockefeller University · U01 · FY2021 · AI